当前位置：
X-MOL 学术
›
Bioelectrochemistry
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Corrigendum to "PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice" [Bioelectrochemistry 2021 (140) 107832].
Bioelectrochemistry ( IF 4.8 ) Pub Date : 2021-06-12 , DOI: 10.1016/j.bioelechem.2021.107865 Masa Bosnjak 1 , Tanja Jesenko 2 , Bostjan Markelc 3 , Larisa Janzic 4 , Maja Cemazar 5 , Gregor Sersa 3
中文翻译：
“PARP 抑制剂奥拉帕尼有可能提高电化学疗法对小鼠 BRCA1 突变乳腺癌的有效性”的更正 [Bioelectrochemistry 2021 (140) 107832]。
更新日期：2021-06-11
Bioelectrochemistry ( IF 4.8 ) Pub Date : 2021-06-12 , DOI: 10.1016/j.bioelechem.2021.107865 Masa Bosnjak 1 , Tanja Jesenko 2 , Bostjan Markelc 3 , Larisa Janzic 4 , Maja Cemazar 5 , Gregor Sersa 3
Affiliation
中文翻译：
“PARP 抑制剂奥拉帕尼有可能提高电化学疗法对小鼠 BRCA1 突变乳腺癌的有效性”的更正 [Bioelectrochemistry 2021 (140) 107832]。
京公网安备 11010802027423号